Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
schizophrenia
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
$
30.00
Add to cart
Details
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
$
30.00
Add to cart
Details
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
$
30.00
Add to cart
Details
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
$
30.00
Add to cart
Details
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
$
30.00
Add to cart
Details
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
$
30.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
$
30.00
Add to cart
Details
Exercise as a Treatment for Schizophrenia: A Review
$
30.00
Add to cart
Details
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
$
30.00
Add to cart
Details
Gender and Schizophrenia
$
30.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
30.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
George Harrison, MD: Priapism and Quetiapine: A Case Report
$
30.00
Add to cart
Details
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
$
30.00
Add to cart
Details
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis
$
30.00
Add to cart
Details
Gwenn S. Smith, PhD: Applications of Neuroreceptor Imaging to Psychiatry Research
$
30.00
Add to cart
Details
Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
$
30.00
Add to cart
Details
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
$
30.00
Add to cart
Details
Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
$
30.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
$
0.00
Add to cart
Details
Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report
$
30.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
30.00
Add to cart
Details
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
$
30.00
Add to cart
Details
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Physical Activity Diminishes Symptomatic Decline in Chronic Schizophrenia: A Systematic Review
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 2, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
$
0.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Schizophrenia and Valproate
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
$
30.00
Add to cart
Details
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
$
30.00
Add to cart
Details
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
$
30.00
Add to cart
Details
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
Takefumi Suzuki, MD, PhD: A Potentially Aborted Neuroleptic Malignant Syndrome Following Seclusion Against Uncontrollable Water Intoxication
$
30.00
Add to cart
Details
1
2
Next
Page load link
Go to Top
